BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38401458)

  • 1. Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: Synthesis, computational and pharmacological study.
    Jevtić II; Suručić RV; Tovilović-Kovačević G; Zogović N; Kostić-Rajačić SV; Andrić DB; Penjišević JZ
    Bioorg Med Chem; 2024 Mar; 101():117649. PubMed ID: 38401458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.
    Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Grishchenko MV; Lushchekina SV; Astakhova TY; Serebryakova OG; Timokhina EN; Zhilina EF; Shchegolkov EV; Ulitko MV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tacrine-acridine hybrids as promising multifunctional drugs for potential treatment of Alzheimer's disease.
    Chufarova N; Czarnecka K; Skibiński R; Cuchra M; Majsterek I; Szymański P
    Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800050. PubMed ID: 29870588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
    Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, molecular docking and molecular dynamics studies of novel tacrine-carbamate derivatives as potent cholinesterase inhibitors.
    Ozten O; Zengin Kurt B; Sonmez F; Dogan B; Durdagi S
    Bioorg Chem; 2021 Oct; 115():105225. PubMed ID: 34364052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease.
    Zhang C; Du QY; Chen LD; Wu WH; Liao SY; Yu LH; Liang XT
    Eur J Med Chem; 2016 Jun; 116():200-209. PubMed ID: 27061983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease.
    Wang N; Jia W; Wang J; Yang Z; Liu Y; Huang D; Mei X; Xiong X; Shi J; Tang Y; Chen G; Di D; Hou Y; Liu Y
    Bioorg Chem; 2024 Feb; 143():107010. PubMed ID: 38056387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Long J; Qin F; Luo J; Zhong G; Huang S; Jing L; Yi T; Liu J; Jiang N
    Bioorg Chem; 2024 Feb; 143():107026. PubMed ID: 38103330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design Synthesis and
    Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
    Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent Based on Tacrine for Theranostics.
    Meena VK; Chaturvedi S; Sharma RK; Mishra AK; Hazari PP
    Mol Pharm; 2019 Jun; 16(6):2296-2308. PubMed ID: 31059278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents.
    Babaee S; Chehardoli G; Akbarzadeh T; Zolfigol MA; Mahdavi M; Rastegari A; Homayouni Moghadam F; Najafi Z
    Chem Biodivers; 2021 Jun; 18(6):e2000924. PubMed ID: 33861892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
    Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
    Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.